Narhex Life Sciences Limited (ASX: NLS) is an Australian biotechnology company based in Melbourne. Its principal focus is to develop and commercialize its anti-HIV protease inhibitor DG17. DG17 is the water-soluble prodrug of the active anti-HIV drug DG35. When DG17 is administered to animals or...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.